These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24278791)

  • 1. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Symptom Severity: Stress Management Skills are Related to Lower Illness Burden.
    Lattie EG; Antoni MH; Fletcher MA; Czaja S; Perdomo D; Sala A; Nair S; Fu SH; Penedo FJ; Klimas N
    Fatigue; 2013; 1(4):. PubMed ID: 24278791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ; Sunnquist M; Jason LA; Newton JL
    BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shadow Burden of Undiagnosed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) on Society: Retrospective and Prospective-In Light of COVID-19.
    Araja D; Berkis U; Lunga A; Murovska M
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis.
    Escorihuela RM; Capdevila L; Castro JR; Zaragozà MC; Maurel S; Alegre J; Castro-Marrero J
    J Transl Med; 2020 Jan; 18(1):4. PubMed ID: 31906988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient-reported outcome measures (PROMs).
    Haywood KL; Collin SM; Crawley E
    Child Care Health Dev; 2014 Nov; 40(6):806-24. PubMed ID: 24661148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children's experiences of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review and meta-ethnography of qualitative studies.
    Parslow RM; Harris S; Broughton J; Alattas A; Crawley E; Haywood K; Shaw A
    BMJ Open; 2017 Jan; 7(1):e012633. PubMed ID: 28087544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate and objective determination of myalgic encephalomyelitis/chronic fatigue syndrome disease severity with a wearable sensor.
    Palombo T; Campos A; Vernon SD; Roundy S
    J Transl Med; 2020 Nov; 18(1):423. PubMed ID: 33168001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
    Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.
    Maksoud R; Balinas C; Holden S; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2021 Feb; 19(1):81. PubMed ID: 33596913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for Developing Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Following Infectious Mononucleosis.
    Jason LA; Cotler J; Islam MF; Furst J; Katz BZ
    J Rehabil Ther; 2022; 4(1):1-5. PubMed ID: 35350440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients.
    Johnston SC; Staines DR; Marshall-Gradisnik SM
    Clin Epidemiol; 2016; 8():97-107. PubMed ID: 27279748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Health-Related Quality of Life in Adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Impact of Core Symptoms.
    Roma M; Marden CL; Flaherty MAK; Jasion SE; Cranston EM; Rowe PC
    Front Pediatr; 2019; 7():26. PubMed ID: 30828572
    [No Abstract]   [Full Text] [Related]  

  • 16. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC
    Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important factors to consider when treating children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): perspectives of health professionals from specialist services.
    Parslow RM; Shaw A; Haywood KL; Crawley E
    BMC Pediatr; 2017 Feb; 17(1):43. PubMed ID: 28143516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study investigating the utility of a specialized online symptom management program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome as compared to an online meditation program.
    Arroll MA; Attree EA; Marshall CL; Dancey CP
    Psychol Res Behav Manag; 2014; 7():213-21. PubMed ID: 25214803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.